Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Capecitabine is an orally-administered chemotherapeutic agent used in the treatment of metastatic breast and colorectal cancers. Capecitabine is a prodrug, which is enzymatically converted to fluorouracil (antimetabolite) in the tumor, where it inhibits DNA synthesis and slows growth of tumor tissue.
Capecitabine is a prescription medication used to treat breast cancer and cancer of the colon or rectum. Capecitabine belongs to a group of drugs called antimetabolites which work by interfering with DNA production, stopping cells from multiplying. The medication comes in tablet form and is usually taken twice daily, within 30 minutes after the end of a meal. Cancer clinical treatment projects have led to the increasing demand for Capecitabine. Increasing Cancer incidence across the globe, especially in the Asia-Pacific is another major factor, driving the growth of the Capecitabine market during the forecast period.
The report details the trend, potential and market size of Capecitabine market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Capecitabinemarket, defines the market attractiveness level of Capecitabine market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Capecitabine industry, describes the types of Capecitabine market, the applications of major players and the market size, and deeply analyzes the current situation of the global Capecitabine market and the development prospects and opportunities of Capecitabine industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Capecitabine market in Chapter 13.
By Player:
Hengrui Medicine
Hikma
Mylan
Teva
Cipla
Roche
Hetero
Reliance Group
By Type:
500 mg
150 mg
By End-User:
Breast Cancer
Colorectal Cancer
Stomach Cancer
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Capecitabine Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Capecitabine Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Capecitabine Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Capecitabine Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Capecitabine Market Analysis and Outlook to 2022
-
7.1 Global Capecitabine Consumption (2017-2022)
-
7.2 United States Capecitabine Consumption (2017-2022)
-
7.3 Europe Capecitabine Consumption (2017-2022)
-
7.4 China Capecitabine Consumption (2017-2022)
-
7.5 Japan Capecitabine Consumption (2017-2022)
-
7.6 India Capecitabine Consumption (2017-2022)
-
7.7 South Korea Capecitabine Consumption (2017-2022)
8 Region and Country-wise Capecitabine Market Analysis and Outlook to 2028
-
8.1 Global Capecitabine Consumption Forecast (2022-2028)
-
8.2 United States Capecitabine Consumption Forecast (2022-2028)
-
8.3 Europe Capecitabine Consumption Forecast (2022-2028)
-
8.4 China Capecitabine Consumption Forecast (2022-2028)
-
8.5 Japan Capecitabine Consumption Forecast (2022-2028)
-
8.6 India Capecitabine Consumption Forecast (2022-2028)
-
8.7 South Korea Capecitabine Consumption Forecast (2022-2028)
9 Global Capecitabine Market Outlook by Types and Applications to 2022
-
9.1 Global Capecitabine Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global 500 mg Consumption and Growth Rate (2017-2022)
-
9.1.2 Global 150 mg Consumption and Growth Rate (2017-2022)
-
9.2 Global Capecitabine Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Breast Cancer Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Colorectal Cancer Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Stomach Cancer Consumption and Growth Rate (2017-2022)
10 Global Capecitabine Market Outlook by Types and Applications to 2028
-
10.1 Global Capecitabine Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global 500 mg Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global 150 mg Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Capecitabine Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Breast Cancer Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Colorectal Cancer Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Stomach Cancer Consumption Forecast and Growth Rate (2022-2028)
11 Global Capecitabine Import and Export Analysis (Top 5 Countries)
-
11.1 Global Capecitabine Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Capecitabine Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Capecitabine Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Capecitabine Market Competitive Analysis
-
14.1 Hengrui Medicine
-
14.1.1 Hengrui Medicine Company Details
-
14.1.2 Hengrui Medicine Capecitabine Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Hengrui Medicine Capecitabine Product and Service
-
14.2 Hikma
-
14.2.1 Hikma Company Details
-
14.2.2 Hikma Capecitabine Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Hikma Capecitabine Product and Service
-
14.3 Mylan
-
14.3.1 Mylan Company Details
-
14.3.2 Mylan Capecitabine Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Mylan Capecitabine Product and Service
-
14.4 Teva
-
14.4.1 Teva Company Details
-
14.4.2 Teva Capecitabine Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Teva Capecitabine Product and Service
-
14.5 Cipla
-
14.5.1 Cipla Company Details
-
14.5.2 Cipla Capecitabine Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Cipla Capecitabine Product and Service
-
14.6 Roche
-
14.6.1 Roche Company Details
-
14.6.2 Roche Capecitabine Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Roche Capecitabine Product and Service
-
14.7 Hetero
-
14.7.1 Hetero Company Details
-
14.7.2 Hetero Capecitabine Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 Hetero Capecitabine Product and Service
-
14.8 Reliance Group
-
14.8.1 Reliance Group Company Details
-
14.8.2 Reliance Group Capecitabine Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 Reliance Group Capecitabine Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Capecitabine
-
Figure Capecitabine Picture
-
Table Global Capecitabine Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Capecitabine Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Capecitabine Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Capecitabine Consumption by Country (2017-2022)
-
Figure United States Capecitabine Consumption and Growth Rate (2017-2022)
-
Table Europe Capecitabine Consumption and Growth Rate (2017-2022)
-
Figure China Capecitabine Consumption and Growth Rate (2017-2022)
-
Figure Japan Capecitabine Consumption and Growth Rate (2017-2022)
-
Figure India Capecitabine Consumption and Growth Rate (2017-2022)
-
Figure South Korea Capecitabine Consumption and Growth Rate (2017-2022)
-
Figure Global Capecitabine Consumption Forecast by Country (2022-2028)
-
Figure United States Capecitabine Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Capecitabine Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Capecitabine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Capecitabine Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Capecitabine Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Capecitabine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global 500 mg Consumption and Growth Rate (2017-2022)
-
Figure Global 150 mg Consumption and Growth Rate (2017-2022)
-
Figure Global Breast Cancer Consumption and Growth Rate (2017-2022)
-
Figure Global Colorectal Cancer Consumption and Growth Rate (2017-2022)
-
Figure Global Stomach Cancer Consumption and Growth Rate (2017-2022)
-
Figure Global 500 mg Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global 150 mg Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Breast Cancer Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Colorectal Cancer Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Stomach Cancer Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Capecitabine Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Capecitabine Export by Region (Top 5 Countries) (2017-2028)
-
Table Hengrui Medicine (Foundation Year, Company Profile and etc.)
-
Table Hengrui Medicine Capecitabine Sales, Price, Value and Gross Profit (2017-2022)
-
Table Hengrui Medicine Capecitabine Product and Service
-
Table Hikma (Foundation Year, Company Profile and etc.)
-
Table Hikma Capecitabine Sales, Price, Value and Gross Profit (2017-2022)
-
Table Hikma Capecitabine Product and Service
-
Table Mylan (Foundation Year, Company Profile and etc.)
-
Table Mylan Capecitabine Sales, Price, Value and Gross Profit (2017-2022)
-
Table Mylan Capecitabine Product and Service
-
Table Teva (Foundation Year, Company Profile and etc.)
-
Table Teva Capecitabine Sales, Price, Value and Gross Profit (2017-2022)
-
Table Teva Capecitabine Product and Service
-
Table Cipla (Foundation Year, Company Profile and etc.)
-
Table Cipla Capecitabine Sales, Price, Value and Gross Profit (2017-2022)
-
Table Cipla Capecitabine Product and Service
-
Table Roche (Foundation Year, Company Profile and etc.)
-
Table Roche Capecitabine Sales, Price, Value and Gross Profit (2017-2022)
-
Table Roche Capecitabine Product and Service
-
Table Hetero (Foundation Year, Company Profile and etc.)
-
Table Hetero Capecitabine Sales, Price, Value and Gross Profit (2017-2022)
-
Table Hetero Capecitabine Product and Service
-
Table Reliance Group (Foundation Year, Company Profile and etc.)
-
Table Reliance Group Capecitabine Sales, Price, Value and Gross Profit (2017-2022)
-
Table Reliance Group Capecitabine Product and Service
-
